PMC:7784824 / 7447-7949
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 151 | 364-374 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 152 | 484-494 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 153 | 250-258 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 154 | 413-421 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 155 | 444-452 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T81 | 0-330 | Sentence | denotes | The main goal of this study was to evaluate the performance of 5 five Point-Of-Care antibody Tests, one chemiluminescence microparticle immunoassay (CMIA), one chemiluminescence immunoassay (CLIA) and 7 enzyme-linked immunosorbent assays (ELISA) for COVID-19 serology in an attempt to validate and select the best performing ones. |
| T82 | 331-502 | Sentence | denotes | Secondly, we discuss the role of SARS-CoV-2 serology in the process of diagnosing COVID-19 disease in presumable COVID-19 cases with sequential negative SARS-CoV-2 RT-PCR. |